What is Oruka Therapeutics, Inc.'s total revenue?

Oruka Therapeutics, Inc. (ORKA) reported total revenue of $0 in Q2 2024.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Oruka Therapeutics, Inc. ORKA Total Revenue

Discontinued — last reported Q2 '24

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Eli LillyLLY

$19.8B+55.5%

Johnson & JohnsonJNJ

$24.06B+9.9%

AmgenAMGN

$8.62B+5.8%

AbbVieABBV

$15B+12.4%

Kymera TherapeuticsKYMR

$34.37M+55.5%

Other financials

Income statement

See full

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$4.36B+533%

Enterprise value$4.32B+690%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed August 1, 2024, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s total revenue?: Oruka Therapeutics, Inc. (ORKA) reported total revenue of $0 in Q2 2024.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.